id	sid	eid	entity	type
dti-1415	1	1	13	CARDINAL
dti-1415	1	2	2019	DATE
dti-1415	1	3	10.1177/1177392819861987	CARDINAL
dti-1415	1	4	4.0	CARDINAL
dti-1415	3	1	43-year-old	DATE
dti-1415	3	2	monthly	DATE
dti-1415	3	3	600 mg	QUANTITY
dti-1415	3	4	the last 15 months	DATE
dti-1415	5	1	2-week	DATE
dti-1415	6	1	160/94 mm hg	QUANTITY
dti-1415	6	2	93 bpm	QUANTITY
dti-1415	6	3	98%	PERCENT
dti-1415	8	1	3.2 mg	QUANTITY
dti-1415	8	2	0.5 mg	QUANTITY
dti-1415	8	3	5.113	CARDINAL
dti-1415	8	4	250	CARDINAL
dti-1415	11	1	53	CARDINAL
dti-1415	12	1	0.85	CARDINAL
dti-1415	12	2	22 mm	QUANTITY
dti-1415	13	1	4 days later	DATE
dti-1415	15	1	24 kg/m2	QUANTITY
dti-1415	16	1	0.41 µg/l	QUANTITY
dti-1415	17	1	thrombophilia	GPE
dti-1415	17	2	3 months	DATE
dti-1415	18	1	6 months	DATE
dti-1415	19	1	0.3 mg	QUANTITY
dti-1415	19	2	90 ng/	QUANTITY
dti-1415	20	1	3 months	DATE
dti-1415	21	1	naranjo	PERSON
dti-1415	21	2	adr	ORG
dti-1415	21	3	adr	ORG
dti-1415	21	4	6	CARDINAL
dti-1415	23	1	omalizumab	PERSON
dti-1415	24	1	crhistian-mario oblitas1	LAW
dti-1415	24	2	francisco galeano-valle1,2	PERSON
dti-1415	24	3	laura vela-de la cruz1	PERSON
dti-1415	24	4	jorge del toro	PERSON
dti-1415	24	5	pablo demelo-rodríguez1,2	PERSON
dti-1415	24	6	universitario gregorio marañón	PERSON
dti-1415	24	7	madrid	GPE
dti-1415	24	8	spain	GPE
dti-1415	25	1	2instituto de investigación sanitaria gregorio marañón	ORG
dti-1415	25	2	madrid	GPE
dti-1415	25	3	spain	GPE
dti-1415	26	1	43-year-old	DATE
dti-1415	26	2	monthly	DATE
dti-1415	26	3	600 mg	QUANTITY
dti-1415	26	4	the last 15 months	DATE
dti-1415	27	1	2-week	DATE
dti-1415	31	1	naranjo	PERSON
dti-1415	31	2	adr	ORG
dti-1415	31	3	adr	ORG
dti-1415	31	4	6	CARDINAL
dti-1415	32	1	omalizumab	PERSON
dti-1415	35	1	may 31,	DATE
dti-1415	35	2	2019	DATE
dti-1415	36	1	june 11, 2019	DATE
dti-1415	39	1	pablo demelo-rodríguez	PERSON
dti-1415	39	2	universitario gregorio marañón	PERSON
dti-1415	39	3	46	DATE
dti-1415	39	4	28007	DATE
dti-1415	39	5	madrid	GPE
dti-1415	39	6	spain	GPE
dti-1415	41	1	861987	DATE
dti-1415	41	2	al letter2019 https://uk.sagepub.com/en-gb/journals-permissions mailto:pbdemelo@hotmail.com 2	ORG
dti-1415	46	1	thrombosis6	PERSON
dti-1415	47	1	5-year	DATE
dti-1415	47	2	7857	DATE
dti-1415	48	1	3.2	CARDINAL
dti-1415	48	2	95%	PERCENT
dti-1415	50	1	2.4-4.3	CARDINAL
dti-1415	50	2	1.5	CARDINAL
dti-1415	50	3	95%	PERCENT
dti-1415	50	4	1000	CARDINAL
dti-1415	51	1	the us food and drug administration8	ORG
dti-1415	51	2	september 26, 2014	DATE
dti-1415	53	1	25	CARDINAL
dti-1415	53	2	2	CARDINAL
dti-1415	54	1	at least 6 months	DATE
dti-1415	61	1	francisco galeano-valle	PERSON
dti-1415	61	2	1	CARDINAL
dti-1415	65	1	2	CARDINAL
dti-1415	65	2	naranjo	PERSON
dti-1415	65	3	ea	CARDINAL
dti-1415	67	1	clin pharmacol	ORG
dti-1415	68	1	1981;30:239–245	CARDINAL
dti-1415	69	1	3	CARDINAL
dti-1415	71	1	multidiscip respir med.	ORG
dti-1415	72	1	r. serial	PERSON
dti-1415	73	1	clin	PERSON
dti-1415	74	1	2017;42:667–669	CARDINAL
dti-1415	75	1	5	CARDINAL
dti-1415	75	2	gumuslu s. d-dimer	PERSON
dti-1415	76	1	opin biol	PERSON
dti-1415	78	1	6	CARDINAL
dti-1415	79	1	narukonda s	PERSON
dti-1415	79	2	joshi m.	PERSON
dti-1415	80	1	2017;5:2324709617724176	DATE
dti-1415	83	1	clin immunol	PERSON
dti-1415	84	1	8	CARDINAL
dti-1415	85	1	fda	ORG
dti-1415	85	2	fda	ORG
dti-1415	87	1	https://www.fda	PERSON
dti-1415	88	1	september, 2014	DATE
dti-1415	89	1	january 22, 2019	DATE
dti-1415	90	1	9	CARDINAL
dti-1415	90	2	rothman kj	PERSON
dti-1415	90	3	bradley ms	PERSON
dti-1415	90	4	carrigan g	PERSON
dti-1415	90	5	md	GPE
dti-1415	90	6	chen h.	PERSON
dti-1415	90	7	25	CARDINAL
dti-1415	91	1	clin immunol	PERSON
dti-1415	93	1	10	CARDINAL
dti-1415	94	1	peñaloza-martínez e	PERSON
dti-1415	94	2	demelo-rodríguez p	ORG
dti-1415	95	1	ann med.	PERSON
dti-1415	96	1	2018;50:666–674	CARDINAL
dti-1415	97	1	https://orcid.org/0000-0003-1321-6866 https://orcid.org/0000-0003-1321-6866	PRODUCT